Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Gynecologic 13Tumor-Agnostic 11Gastrointestinal 11Thoracic 8Genitourinary 8Other hematologic neoplasm 6Lymphoid 5Dermatologic 5Breast 5Head & Neck 4Plasma cell 3Other solid neoplasm 3NET 3Endocrine 3CNS 3Sarcoma 2Myeloid 2Classical hematology 2

Conditions

Neuroendocrine Tumors 3

Interventions

Surveys and Questionnaires 8Blood Specimen Collection 7lutetium Lu 177 dotatate 6Surgical Procedures, Operative 6Magnetic Resonance Spectroscopy 6Adrenalectomy 5Observation 4Transurethral Resection of Prostate 3Thyroidectomy 3Positron-Emission Tomography 3Lymph Node Excision 3Data Collection 3telotristat ethyl 2surufatinib 2gallium Ga 68 dotatate 2Somatostatin 2Radionuclide Imaging 2Radiofrequency Ablation 2Everolimus 2Drug Therapy 2Biopsy 2somapacitan 1methyl hydroxyethyl cellulose 1lanreotide 1fluorodopa F 18 1exemestane 1delta 24-sterol reductase 1copper dotatate CU-64 1Whole Body Imaging 1Walking 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Data Collection × Endocrine × Clear all
NCT03562091 2020-08-28

OPERA

Ipsen

Completed
115 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03112694 2020-06-02

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

Ipsen

Completed
93 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03220087 2018-12-21

RECOSY

Ipsen

Completed
142 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡